ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
ESSA Pharma Inc

ESSA Pharma Inc (EPIX)

1.725
0.015
( 0.88% )
更新日時: 05:21:18

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
1.725
買値
1.72
売値
1.73
出来高
135,085
1.6906 日の範囲 1.74
1.40 52 週間の範囲 11.67
時価総額
前日終値
1.71
始値
1.70
最終取引時間
05:22:56
財務取引量
US$ 230,511
VWAP
1.7064
平均取引量 (3 か月)
902,153
発行済株式数
44,368,959
配当利回り
-
PER
-2.87
1 株当たり利益 (EPS)
-0.6
歳入
-
純利益
-26.58M

ESSA Pharma Inc について

ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Vancouver, British Columbia, Can
設立
-
ESSA Pharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker EPIX. The last closing price for ESSA Pharma was US$1.71. Over the last year, ESSA Pharma shares have traded in a share price range of US$ 1.40 to US$ 11.67.

ESSA Pharma currently has 44,368,959 shares in issue. The market capitalisation of ESSA Pharma is US$75.87 million. ESSA Pharma has a price to earnings ratio (PE ratio) of -2.87.

EPIX 最新ニュース

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire SOUTH SAN...

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress

ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 13, 2024 Combination of...

ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference

ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.075-4.166666666671.81.821.684065361.72725641CS
4-0.105-5.737704918031.831.891.664082291.76433069CS
12-5.325-75.53191489367.057.691.49021531.65949473CS
26-4.085-70.30981067135.817.691.44478441.900616CS
52-3.565-67.39130434785.2911.671.42796013.15175031CS
156-9.885-85.14211886311.6114.881.44875044.24803176CS
260-3.775-68.63636363645.5361.43772926.97448606CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
UPCUniverse Pharmaceuticals Inc
US$ 2.92
(178.10%)
91.51M
LIFWMSP Recovery Inc
US$ 3.27
(105.66%)
19.69M
GXAIGaxos ai Inc
US$ 2.51
(76.76%)
139.55M
SMXSMX Security Matters Public Company
US$ 0.5098
(71.42%)
429.82M
SBETSharpLink Gaming Inc
US$ 0.8896
(69.77%)
25.71M
ORISOriental Rise Holdings Ltd
US$ 3.68
(-93.43%)
24.02M
LICNLichen China Limited
US$ 0.4662
(-78.01%)
174.8M
MYNAMynaric AG
US$ 0.5001
(-64.53%)
3.25M
CEROCERo Therapeutics Holdings Inc
US$ 0.1157
(-39.58%)
32.65M
BJDXBluejay Diagnostics Inc
US$ 4.16
(-32.90%)
409.24k
SMXSMX Security Matters Public Company
US$ 0.5098
(71.42%)
429.82M
SOUNSoundHound AI Inc
US$ 14.7518
(10.67%)
196.43M
LICNLichen China Limited
US$ 0.4662
(-78.01%)
174.8M
NVDANVIDIA Corporation
US$ 142.275
(-1.92%)
144.87M
SVMHSRIVARU Holding Ltd
US$ 0.03005
(-14.14%)
143.84M

EPIX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock